Amazentis Pioneers First Sports Nutrition Program with Mitopure™ (Urolithin A)
Retrieved on:
Tuesday, May 11, 2021
This new clinical study aims to expand the clinical evidence of Mitopure in a younger and more athletic population.\nThis press release features multimedia.
Key Points:
- This new clinical study aims to expand the clinical evidence of Mitopure in a younger and more athletic population.\nThis press release features multimedia.
- View the full release here: https://www.businesswire.com/news/home/20210511005901/en/\nProfessional basketball player Joel Embiid has been taking Mitopure for several months.
- Scientific evidence combined with positive feedback from both amateur and professional athletes who have been taking Mitopure has served as a catalyst to expand into sports nutrition product applications.
- This novel, science-first brand was developed by Amazentis on the belief that uncompromising research can unlock a new class of clinically validated nutritional products.